Brainsway Q1 Earnings Call Highlights

2 hours ago 2

MarketBeat

Wed, May 13, 2026 astatine 9:07 AM CDT 7 min read

Brainsway logo

Key Points

Interested successful Brainsway Ltd. Sponsored ADR? Here are 5 stocks we similar better.
BrainsWay posted beardown Q1 results with gross up 35% twelvemonth implicit twelvemonth to $15.5 million, its 11th consecutive profitable quarter, and adjusted EBITDA much than doubling to $2.8 million. The institution besides shipped 117 Deep TMS systems, lifting its installed basal to astir 1,820 systems.
Recurring gross and reimbursement advancement are accelerating, with remaining show obligations rising 25% to $75 cardinal and the institution saying it expects SWIFT reimbursement sum for 40 cardinal to 50 cardinal lives by year-end. BrainsWay besides highlighted broader payer support, including expanded teen slump sum and reduced anterior authorization barriers.
BrainsWay reaffirmed full-year 2026 guidance for gross of $66 cardinal to $68 million, implying 27% to 30% growth, and adjusted EBITDA of $12 cardinal to $14 million. Management besides said it plans an FDA submission for PTSD symptoms successful patients with large depressive upset and is advancing studies successful intoxicant usage disorder.

Brainsway (NASDAQ:BWAY) reported a beardown commencement to 2026, with first-quarter gross rising 35% twelvemonth implicit twelvemonth arsenic the institution expanded placements of its Deep TMS systems and continued to physique its recurring gross base.

Chief Executive Officer Hadar Levy said connected the company’s net telephone that gross for the 3 months ended March 31, 2026, totaled $15.5 million, compared with $11.5 cardinal successful the prior-year period. The institution shipped 117 Deep TMS systems during the quarter, a 44% summation from the aforesaid play past year, bringing its full installed basal to astir 1,820 systems.

→ Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum

Levy said the 4th marked BrainsWay’s 11th consecutive 4th of profitability, supported by borderline enlargement and the company’s recurring model. Net income roseate to $2.3 cardinal from $1.1 cardinal a twelvemonth earlier, portion adjusted EBITDA accrued 119% to $2.8 cardinal from $1.3 million.

Recurring Contracts and Backlog Continue to Expand

BrainsWay reported remaining show obligations of $75 cardinal arsenic of March 31, 2026, up 25% twelvemonth implicit year. Levy said astir caller contracts signed during the 4th were multi-year agreements, which helium described arsenic grounds of request for the company’s exertion and the occurrence of its absorption connected endeavor customers.

→ MercadoLibre Boldly Invests successful Growth: Discount Deepens

Chief Financial Officer Ido Marom said gross nett accrued 35% to $11.6 million, compared with $8.6 cardinal successful the archetypal 4th of 2025. Operating income was astir $2 million, up from $0.6 cardinal a twelvemonth earlier.

Read Entire Article